The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adherence to novel oral anticancer therapies in the phase I setting: The Royal Marsden experience.
 
Maxime Chenard-Poirier
No Relationships to Disclose
 
Joo Ern Ang
No Relationships to Disclose
 
Samuel John Harris
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Alvaro Henrique Ingles Garces
No Relationships to Disclose
 
Satyanarayana Seeramreddi
No Relationships to Disclose
 
Raghav Sundar
No Relationships to Disclose
 
Dearbhaile Catherine Collins
Honoraria - Janssen-Cilag
Travel, Accommodations, Expenses - Celgene
 
Malaka Ameratunga
No Relationships to Disclose
 
Juanita Suzanne Lopez
No Relationships to Disclose
 
Johann S. De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Genentech/Roche; Sanofi
Research Funding - AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); PARP inhibitors and DNA repair defects (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex
 
Udai Banerji
Employment - Institute of Cancer Research
Consulting or Advisory Role - Astex Pharmaceuticals; Novartis
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Onyx (Inst)